Intercept Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Intercept Pharmaceuticals has a total shareholder equity of $71.8M and total debt of $223.9M, which brings its debt-to-equity ratio to 311.6%. Its total assets and total liabilities are $393.2M and $321.3M respectively.
Key information
311.6%
Debt to equity ratio
US$223.86m
Debt
| Interest coverage ratio | n/a |
| Cash | US$322.71m |
| Equity | US$71.85m |
| Total liabilities | US$321.32m |
| Total assets | US$393.16m |
Recent financial health updates
Intercept Pharmaceuticals (NASDAQ:ICPT) Has Debt But No Earnings; Should You Worry?
Apr 11
Health Check: How Prudently Does Intercept Pharmaceuticals (NASDAQ:ICPT) Use Debt?
Dec 20Recent updates
Revenues Working Against Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT) Share Price Following 25% Dive
Jun 08Intercept Pharmaceuticals (NASDAQ:ICPT) Has Debt But No Earnings; Should You Worry?
Apr 11Health Check: How Prudently Does Intercept Pharmaceuticals (NASDAQ:ICPT) Use Debt?
Dec 20Intercept touts Ocaliva benefit in transplant-free survival in liver disease type
Sep 20Intercept cuts debt further with deal to exchange convertible notes
Sep 02Intercept reduces debt with repurchases of $327.9M convertible notes
Aug 19Intercept Pharmaceuticals: Too Risky To Buy At This Stage
Aug 13Intercept Pharma Q2 2022 Earnings Preview
Aug 02Intercept to resubmit for FDA approval of NASH candidate after new analysis
Jul 07Intercept: Increase Of Ocaliva Sales And A Few Catalysts
May 23Need To Know: Analysts Are Much More Bullish On Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
May 10Intercept: Opportunity To Buy On Potential NDA Resubmission Of Ocaliva For NASH
Mar 05Intercept names Andrew Saik as chief financial officer
Jun 07Intercept Pharmaceuticals slides as FDA restricts Ocaliva use
May 26Financial Position Analysis
Short Term Liabilities: ICPT's short term assets ($383.4M) exceed its short term liabilities ($90.8M).
Long Term Liabilities: ICPT's short term assets ($383.4M) exceed its long term liabilities ($230.5M).
Debt to Equity History and Analysis
Debt Level: ICPT has more cash than its total debt.
Reducing Debt: ICPT's debt to equity ratio has reduced from 383.3% to 311.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ICPT has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ICPT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.